Insider Ledger
Aura Biosciences, Inc. (AURA) insider buying and SEC filings
Aura Biosciences, Inc. · CIK 1501796
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Biological Products, (No Diagnostic Substances)
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$39.9M
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jun 16, 2026 | Sale | Anthony S Gibney (CFO) sold 12,824 shares at $6.42 ($82K). Holdings down 5% to 265,354 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 16, 2026 |
| May 7, 2026 | Sale | David E. Goel (10% owner) sold 6,922,870 shares indirectly at $5.64 ($39.0M). Indirect holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 1 other reporting owner. | SEC filing Filed May 11, 2026 |
| Apr 16, 2026 | Sale | Conor Kilroy (Chief Legal Officer) sold 11,738 shares at about $7.02 ($82K). Holdings down 5% to 217,835 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 16, 2026 |
| Feb 17, 2026 | Sale | Conor Kilroy (Chief Legal Officer) sold 12,079 shares at about $5.05 ($61K). Holdings down 7% to 167,234 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 17, 2026 |
| Feb 17, 2026 | Sale | Mark Plavsic (Chief Technology Officer) sold 15,890 shares at about $5.05 ($80K). Holdings down 8% to 181,397 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 17, 2026 |
| Feb 17, 2026 | Sale | Janet Jill Hopkins (Chief Medical Officer) sold 20,401 shares at about $5.06 ($103K). Holdings down 8% to 232,284 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 17, 2026 |
| Feb 17, 2026 | Sale | Amy Elazzouzi (Senior Vice President, Finance) sold 8,549 shares at about $5.06 ($43K). Holdings down 10% to 75,532 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 17, 2026 |
| Feb 17, 2026 | Sale | los Pinos Elisabet de (CEO and Director) sold 47,648 shares at about $5.06 ($241K). Holdings down 10% to 409,815 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 17, 2026 |
| Jan 20, 2026 | Sale | Amy Elazzouzi (Senior Vice President, Finance) sold 1,581 shares at $4.86 ($8K). Holdings down 2% to 84,081 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 20, 2026 |
| Jan 20, 2026 | Sale | los Pinos Elisabet de (CEO and Director) sold 16,928 shares at about $4.86 ($82K). Holdings down 4% to 457,463 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 20, 2026 |
| Nov 17, 2025 | Sale | Janet Jill Hopkins (Chief Medical Officer) sold 17,109 shares at about $5.42 ($93K). Holdings down 6% to 252,685 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 17, 2025 |
18 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow AURA in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.